Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

5.05
Delayed Data
As of Feb 27
 0.00 / 0.00%
Today’s Change
1.46
Today|||52-Week Range
5.32
+219.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-40.4M-95.3M-59.4M-30.9M
 
 
 
 
 
Depreciation17.3K80.0K331.0K353.0K
 
 
 
 
 
Total Other Cash Flow9.0M3.2M1.9M4.3M
 
 
 
 
 
Funds From Operations-31.4M-92.0M-57.2M-26.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.6M-19.0M16.4M5.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-27.8M-73.1M-73.6M-31.9M
 
 
 
 
 
 
InvestingIncrease In Investments-24.9M-4.7M-10.7M0.00
 
 
 
 
Decrease In Investments1.6M26.3M7.1M5.3M
 
 
 
 
 
Capital Expenditures-21.6K-1.3M-207.0K-15.0K
 
 
 
 
 
Other Investing - Uses0.000.000.00-10.0M
 
 
Net Cash Flow Investing-23.4M20.2M-3.8M-4.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.0024.7M0.0019.8M
 
 
 
Long Term Debt Reduction0.000.00-4.5M-22.4M
 
 
 
Net Proceeds Stock Sale91.0M54.6M35.8M45.8M
 
 
 
 
 
Common Preferred Redeemed-3.2M0.000.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing210.3K879.0K37.0K32.0K
 
 
 
 
 
Net Cash Flow - Financing87.5M78.4M31.3M43.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-165.0K---31.0K-1.0K
 
 
 
 
 
Net Change In Cash36.4M25.6M-46.2M6.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account